Singapore: Taiwan's PharmaEngine licensing partner, Merrimack Pharmaceuticals, and its sublicensing partner, Baxter Inte...
Singapore: HUYA Bioscience International has signed an exclusive license with Fudan University for the ex-China rights t...
Singapore: Australia-based drug discovering company, Phylogica has inked a pact with US-based Genentech, to discover nov...
Singapore: Pharma giant Pfizer has received a complete response letter from the US Food and Drug Administration (FDA) o...
Singapore: Taiwan's PharmaEngine has recieved Taiwan Food and Drug Administration (TFDA) approval for ONIVYDE (irinoteca...
Singapore: Australia-based Cellmid has received patent approval from IP Australia for method of treatment or prevention ...
Singapore: Global pharmaceutical firm, Pfizer, has recieved US Food and Drug Administration (FDA) nod for review of Biol...
Singapore: US-based TNI BioTech, a biotechnology company focused on autoimmune diseases in emerging nations, has partner...
Japan Vaccine, an affiliate of pharmaceutical giant Daiichi Sankyo, and Terumo Corporation have filed an application for...
Singapore: Japanese pharmaceutical major Astellas Pharma has announced that it would cut down its group workforce in hom...
Singapore: Researchers at Montreal Heart Institute has demonstrated positive result from the medication of dalcetrapib i...
Singapore: After years of rejecting approval for Impax's flagship drug Rytary, a treatment for Parkinson's disease, the ...
Singapore: US-based Molecular Targeting Technologies (MTTI) and National Health Research Institutes (NHRI) of Taiwan hav...
Singapore: Australian biotechnology company Virax plans to acquire oncology company AKTivate Therapeutics and its novel ...
Singapore: Agency for Science, Technology and Research (A*STAR) and Duke-National University of Singapore Graduate Medic...
Scientists at the Okayama University in Japan have announced that their studies have revealed how a diabetes drug helps ...
Singapore: GlaxoSmithKline and Theravance have withdrawn license application for the use of inhaled drug fluticasone fur...
Singapore: Global pharma company Novartis has confirmed positive results from two pivotal phase III studies evaluating i...
Singapore: Researchers from the Nanyang Technological University, Singapore have developed a new antibody that has shown...
Singapore: Taiwan based TaiGen Biotechnology has collaborated with R-Pharm, a Russian pharmaceutical company, to develop...
Singapore: Verastem, a biopharmaceutical company focused on discovering and developing drugs to treat breast and other c...
Singapore: Australia and Indonesia are jointly working towards the research to understand prevalence of AIDS and cancer ...
Singapore: Australian biotech firm, Bionomics, has partnered with Merck for research and license agreement for its BNC37...
Singapore: Australia's Medical Research Commercialisation Fund (MRCF) has funded the start-up firm Solvanix, an early st...
Singapore: Pharmaceutical firms, Roche, Meiji Seika Pharma and Fedora have entered into a license agreement for the deve...
Singapore: Taiwan based Delta Electronics has invested in Singapore to develop next-generation infectious disease detec...
Professor (Dr) David Price has been fighting the scourge of respiratory diseases throughout his life and is considered o...
Singapore: Eli Lilly officially opened the Lilly China Research and Development Center (LCRDC) on May 30, keeping with i...
Singapore: Australia-based biopharmaceutical company, Specialised Therapeutics Australia (STA), has achieved positive re...
Singapore: Brisbane-based R&D company Alchemia has recruited the 390th patient for the pivotal phase III clinical tr...
Singapore: Global Non-Small Cell Lung Cancer (NSCLC) treatment market value will increase from USD5.1 billion in 2013 to...
Singapore: Recent worries over antibiotics losing their effectiveness will only be exacerbated by the FDA's latest drug ...
Singapore: US drugmaker, Bristol-Myers Squibb co has said that it is seeking Japanese health regulators approval of its ...
Singapore: Physicians treating rare blood disorders now have more drug treatments to choose from to treat patients. This...
Singapore: Germany's translational drug discovery organization, Lead Discovery Center (LDC), has entered into a licence ...
Singapore: U.S. Food and Drug Administration (FDA) has accepted to review Supplemental New Drug Application (sNDA) for E...
Singapore: Eisai EMEA (Europe, Middle East, Africa, Russia and Oceania), the R&D division of the Japan-based company...
Genzyme, a Sanofi company, announced that the Ministry of Health, Labour and Welfare (MHLW) has granted marketing approv...
Singapore: GE Healthcare Life Sciences plans to open a technology and training laboratory in Turkey by mid-2015 targetti...
Singapore: Takeda Pharmaceutical has terminated the development program for orteronel (TAK-700) for prostate cancer foll...
New Delhi: Panacea Biotec entered into a strategic alliance for R&D and commercialization of drug delivery-based, ge...
Singapore: Shanghai Fosun Pharmaceutical has been listed in CCTV Financial 50 Index Sample Stock, an index created by Sh...
Singapore: Shanghai Pharmaceuticals has entered into a strategic framework cooperation agreement with Secondary Military...
Singapore: RUNX3, a gene that is intensively studied for its function as a tumour suppressor, is likely to be a key and ...
The year 2011 was a year of capturing potential markets and achieving new milestones. Ranbaxy Laboratories became the fi...
Singapore: Patrys received approval to progress its phase I/IIa PAT-SM6 multiple myeloma trial based on safety data from...
Singapore: TB Alliance has started a clinical trial of a new regimen to treat extensively drug-resistant tuberculosis (X...
Singapore: US based oncology biotechnology company, Ignyta, has acquired four targeted oncology development programs fro...
Singapore: MMRGlobal received confirmation of the filings of a divisional application for its antibody technology in Jap...
Singapore: In a bid to further foster new drug research for drug resistant tuberculosis (TB), Wellcome Trust has collabo...
Singapore: Johnson & Johnson plans to establish four regional innovation centers in major life sciences communities ...
Singapore: Amgen has received positive results from its global Phase 2 clinical trial of AMG 334, a fully human monoclon...
Singapore: OccuRx, an Australian biopharmaceutical company developing a new class of drugs to prevent health burden due ...
Singapore: US-based Nektar Therapeutics has revealed positive preclinical data for NKTR-214, a novel cancer immunotherap...
Singapore: A group of international researchers, including from University of Melbourne, have discovered a new class of ...
Singapore: India-based Suven Lifescinces has secured patents for its new chemical entities (NCEs) from Japan, China, New...
Singapore: Israel-based D-Pharm has recieved new patent in the US and China, related to composition and use of THR-18, a...
Singapore: Australia based Novogen's lead candidate, TRXE-009, developed for the treatment of brain cancers, has shown t...
Singapore: A team of scientists from Cancer Science Institute of Singapore (CSI Singapore) at the National University of...
Singapore: Certara, a drug development and drug safety consultancy firm has launched its D360 software in Japan for prov...
Singapore: Chinese biotechnology firm, 3SBio, has signed an exclusive license with Korean firm, DiNonA for the develop...
Singapore: Australia-based clinical-stage drug development company, Invion, initiated and commenced patient enrolment in...
Singapore: Breast cancer therapeutics pipeline has higher innovation in first-in-class molecules, with many new technolo...
Singapore: Ascend Biopharmaceuticals, a Melbourne-based immunotherapy company, plans to begin a Phase 2 clinical trial o...
Singapore: Singapore's biopharmaceutical company, MerLion Pharmaceuticals, has recieved positive results from a phase 2 ...
Singapore: Ally Bridge Group (ABG), a global healthcare-focused investment platform, has expanded its global biopharmace...
Singapore: Women who take aspirin daily may reduce their risk of ovarian cancer by 20 percent, according to a study by s...
Singapore: A small freshwater fish found in many tropical aquariums may hold the key to unlocking one of the leading cau...
Singapore: Otsuka Pharmaceutical received a Complete Response Letter (CRL) from the US FDA regarding the new drug applic...
Singapore: Allied-Bristol Life Sciences, a jointly owned enterprise between Allied Minds and Bristol-Myers Squibb, has a...
Singapore: US based biotech firm, Genocea Biosciences, has identified a cluster of antigens, generated using its ATLAS a...
Singapore: National University of Singapore has demonstrated effectiveness of artesunate, a common herbal-based anti-mal...
Singapore: Danish firm, Mirrx Therapeutics and Australia's Centenary Institute of Cancer Medicine and Cell Biology has f...
Singapore: Japan-based Dainippon Sumitomo Pharma (DSP), has decided to establish an anti-cancer drugs sales company in t...
Singapore: Japanese company, Kyowa Hakko Kirin and Korean firm, Syndax Pharmaceuticals, have entered into a license agre...
Singapore: Cantrixil, a first-in-class experimental chemotherapeutic, developed by Australia/US-based biotech firm Novog...
Singapore: Auspherix, an early stage anti-infectives company developing novel antibiotics to treat resistant bacterial d...
Singapore: Australia and Switzerland based Clinuvel Pharmaceuticals' Singapore subsidiary Vallaurix has successfully com...
Singapore: NephroGenex, pharmaceutical company focused on the development of therapeutics to treat kidney disease, has r...
Singapore: European Medicines Agency (EMA) has accepted Eli Lilly and Boehringer Ingelheim's marketing authorisation app...
Singapore: The Japanese Ministry for Health and Welfare has recently given its nod for Novatris' Cosentyx, that treats p...
Singapore: Australia's Medical Research Commercialisation Fund (MRCF) has invested around $1 million in an early stage a...
Tokyo: Researchers from the RIKEN Center for Integrative Medical Sciences have worked with a number of universities and...
Singapore: Sweden-based company NeuroVive Pharmaceutical's Asia arm has signed a collaboration agreement with Sanofi's a...
Singapore: WuXi PharmaTech, a China-based contract research organization (CRO), has obtained a multiyear license to Adme...
Singapore: Asthma treatment market value will grow from approximately USD15.9 billion in 2013, across eight major countr...
Nemus Bioscience Inc. has announced that the pro-drug of tetrahydrocannabinol (THC) in-licensed from the company's resea...
Singapore: Chinese Food and Drug Administration (CFDA) has approved Israel based D-Pharm to conduct clinical development...
Singapore: In a move to accelerate genome sequencing and bring breakthrough in cancer treatment in the country, UK has...
Tokyo's Mochida Pharmaceutical Co. Ltd. has filed for a new drug application (NDA) for MD-0901 with the Japanese Ministr...
Singapore: Sanofi has terminated NaP2b inhibitors development deal with US based Ardelyx, a clinical-stage biopharmaceut...
Singapore: Global technology firm AB SCIEX and Dalton Pharma Services have formed a research collaboration to develop An...
Singapore: Global experts have commented that the lack of adequate funding was a major drawback that discouraged researc...
Singapore: Australia based drug discovery company, Viralytics, has recieved UK Medicines and Healthcare Products Regulat...
Singapore: Clinical research firm, AMRI, has received a 10-year federal contract award from the National Institutes of H...
Singapore: Singapore start-up and Scotland based TauRx Therapeutics is progressing in its two Phase III clinical trials ...
Singapore: Novartis revealed new clinical data associated with the eye drug Lucentis (ranibizumab) admist a total of 209...
Singapore: Taiwan based Genovate Biotechnology and ScinoPharm have jointly developed the highly potent oral generic drug...
Singapore: Global biopharmaceutical company, Roche, has acquired InterMune, a biotechnology company focused on the resea...
Nasdaq-listed Neurocrine Biosciences has entered into an exclusive collaboration and licensing agreement for the develop...
